Mainz Biomed B.V. (MYNZ) Financials

MYNZ Assets vs Liabilities

DateAssetsLiabilities
Dec. 31, 2024 13.2 million 7.2 million
Sept. 30, 2024 8.5 million 12.6 million
June 30, 2024 8.5 million 12.6 million
March 31, 2024 15.4 million 12.2 million

MYNZ Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2024 ? ?
Sept. 30, 2024 -8.3 million 1.0 million
June 30, 2024 -8.3 million 1.0 million
March 31, 2024 -4.9 million 818991

MYNZ Net Income

No data available :(

MYNZ Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2024 6.2 million 865982 1.1 million
Sept. 30, 2024 977764 - -
June 30, 2024 977764 2.0 million 1.4 million
March 31, 2024 7.1 million - -

MYNZ Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Dec. 31, 2024 2.2 million
Sept. 30, 2024 558751
June 30, 2024 639664
March 31, 2024 442035

MYNZ Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2024 - - - -
Sept. 30, 2024 120660 3.2 million 4.5 million 2.4 million
June 30, 2024 120660 3.2 million 6.9 million 2.4 million
March 31, 2024 261808 2.0 million 3.5 million 1.2 million

MYNZ Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2024 - -
Sept. 30, 2024 520773 201735
June 30, 2024 520773 201735
March 31, 2024 214761 174510

MYNZ

Price: $0.84

52 week price:
0.55
5.62

Earnings Per Share: -5.28 USD

P/E Ratio: -0.15

Exchange: NCM

Sector: Healthcare

Industry: Diagnostics & Research

Country: Germany

Volume: 15400

Market Capitalization: 3.3 million

Links: